Data for gross profit, net profit, operating profit, and cost structure for 2005 till 2011 for the Generic Drugs market are provided in this analysis. Profit margins data are provided for the 4 regions (North America, Europe, APAC and Rest of World). Sample charts are shown below and actual charts are available after purchase.

 
Chart will load here
 
FusionCharts.
 
FusionCharts.
 
Gross Profit and Net Profit Trend ( % ) in Global Generic Drugs Market 2005 - 2011(Source: Lucintel)
Profit Type: |NET PROFIT|Percentage: |2 % Profit Type: |NET PROFIT|Percentage: |0 % Profit Type: |NET PROFIT|Percentage: |-16 % Profit Type: |NET PROFIT|Percentage: |-3 % Profit Type: |NET PROFIT|Percentage: |4 % Profit Type: |NET PROFIT|Percentage: |5 % Profit Type: |NET PROFIT|Percentage: |6 % Profit Type: |GROSS PROFIT|Percentage: |24 % Profit Type: |GROSS PROFIT|Percentage: |25 % Profit Type: |GROSS PROFIT|Percentage: |18 % Profit Type: |GROSS PROFIT|Percentage: |25 % Profit Type: |GROSS PROFIT|Percentage: |27 % Profit Type: |GROSS PROFIT|Percentage: |27 % Profit Type: |GROSS PROFIT|Percentage: |26 %
 
Cost Structure ( % ) for Global Generic Drugs Market 2005 - 2011 (Source: Lucintel)
Expense: |OPERATING PROFIT|Amount: |0.76 ( US $ Bil ) Expense: |OTHER EXPENSES|Amount: |1.22 ( US $ Bil ) Expense: |R & D EXPENSE|Amount: |0.32 ( US $ Bil ) Expense: |S G & A EXPENSE|Amount: |1.76 ( US $ Bil ) Expense: |COST OF GOODS|Amount: |13.85 ( US $ Bil ) Expense: |OPERATING PROFIT|Amount: |0.07 ( US $ Bil ) Expense: |OTHER EXPENSES|Amount: |1.34 ( US $ Bil ) Expense: |R & D EXPENSE|Amount: |0.35 ( US $ Bil ) Expense: |S G & A EXPENSE|Amount: |3.93 ( US $ Bil ) Expense: |COST OF GOODS|Amount: |12.75 ( US $ Bil ) Expense: |OPERATING PROFIT|Amount: |-3.19 ( US $ Bil ) Expense: |OTHER EXPENSES|Amount: |2.55 ( US $ Bil ) Expense: |R & D EXPENSE|Amount: |0.45 ( US $ Bil ) Expense: |S G & A EXPENSE|Amount: |4.64 ( US $ Bil ) Expense: |COST OF GOODS|Amount: |14.56 ( US $ Bil ) Expense: |OPERATING PROFIT|Amount: |-0.77 ( US $ Bil ) Expense: |OTHER EXPENSES|Amount: |3.43 ( US $ Bil ) Expense: |R & D EXPENSE|Amount: |0.58 ( US $ Bil ) Expense: |S G & A EXPENSE|Amount: |4.89 ( US $ Bil ) Expense: |COST OF GOODS|Amount: |19.22 ( US $ Bil ) Expense: |OPERATING PROFIT|Amount: |1.73 ( US $ Bil ) Expense: |OTHER EXPENSES|Amount: |1.61 ( US $ Bil ) Expense: |R & D EXPENSE|Amount: |0.61 ( US $ Bil ) Expense: |S G & A EXPENSE|Amount: |5.14 ( US $ Bil ) Expense: |COST OF GOODS|Amount: |22.02 ( US $ Bil ) Expense: |OPERATING PROFIT|Amount: |1.91 ( US $ Bil ) Expense: |OTHER EXPENSES|Amount: |1.37 ( US $ Bil ) Expense: |R & D EXPENSE|Amount: |0.55 ( US $ Bil ) Expense: |S G & A EXPENSE|Amount: |4.44 ( US $ Bil ) Expense: |COST OF GOODS|Amount: |20.49 ( US $ Bil ) Expense: |OPERATING PROFIT|Amount: |2.21 ( US $ Bil ) Expense: |OTHER EXPENSES|Amount: |0.6 ( US $ Bil ) Expense: |R & D EXPENSE|Amount: |0.41 ( US $ Bil ) Expense: |S G & A EXPENSE|Amount: |3.82 ( US $ Bil ) Expense: |COST OF GOODS|Amount: |18.8 ( US $ Bil )
 
Gross Profit Trend ( % ) in Generic Drugs Market by Region (Source: Lucintel)
Region: |REST OF WORLD|Percentage: |26 % Region: |REST OF WORLD|Percentage: |24 % Region: |REST OF WORLD|Percentage: |19 % Region: |REST OF WORLD|Percentage: |24 % Region: |REST OF WORLD|Percentage: |26 % Region: |REST OF WORLD|Percentage: |25 % Region: |REST OF WORLD|Percentage: |26 % Region: |ASIA PACIFIC|Percentage: |26 % Region: |ASIA PACIFIC|Percentage: |22.73 % Region: |ASIA PACIFIC|Percentage: |17.47 % Region: |ASIA PACIFIC|Percentage: |23.24 % Region: |ASIA PACIFIC|Percentage: |26.85 % Region: |ASIA PACIFIC|Percentage: |26.31 % Region: |ASIA PACIFIC|Percentage: |26.93 % Region: |EUROPEAN|Percentage: |24 % Region: |EUROPEAN|Percentage: |32.12 % Region: |EUROPEAN|Percentage: |26.01 % Region: |EUROPEAN|Percentage: |35.54 % Region: |EUROPEAN|Percentage: |34.09 % Region: |EUROPEAN|Percentage: |33.13 % Region: |EUROPEAN|Percentage: |29.9 % Region: |NORTH AMERICAN|Percentage: |20 % Region: |NORTH AMERICAN|Percentage: |21.05 % Region: |NORTH AMERICAN|Percentage: |10.97 % Region: |NORTH AMERICAN|Percentage: |18.41 % Region: |NORTH AMERICAN|Percentage: |20.46 % Region: |NORTH AMERICAN|Percentage: |21.81 % Region: |NORTH AMERICAN|Percentage: |22.44 %
 
Net Profit Trend ( % ) in Generic Drugs Market by Region (Source: Lucintel)
Region: |REST OF WORLD|Percentage: |3.2 % Region: |REST OF WORLD|Percentage: |2.7 % Region: |REST OF WORLD|Percentage: |-13.7 % Region: |REST OF WORLD|Percentage: |0.06 % Region: |REST OF WORLD|Percentage: |4.9 % Region: |REST OF WORLD|Percentage: |5.6 % Region: |REST OF WORLD|Percentage: |5.1 % Region: |ASIA PACIFIC|Percentage: |2.48 % Region: |ASIA PACIFIC|Percentage: |1.82 % Region: |ASIA PACIFIC|Percentage: |-18.23 % Region: |ASIA PACIFIC|Percentage: |0.15 % Region: |ASIA PACIFIC|Percentage: |4.3 % Region: |ASIA PACIFIC|Percentage: |5.1 % Region: |ASIA PACIFIC|Percentage: |4.83 % Region: |EUROPEAN|Percentage: |-0.6 % Region: |EUROPEAN|Percentage: |-0.58 % Region: |EUROPEAN|Percentage: |-8.94 % Region: |EUROPEAN|Percentage: |2.2 % Region: |EUROPEAN|Percentage: |5.46 % Region: |EUROPEAN|Percentage: |5.1 % Region: |EUROPEAN|Percentage: |6.27 % Region: |NORTH AMERICAN|Percentage: |1.98 % Region: |NORTH AMERICAN|Percentage: |-3.04 % Region: |NORTH AMERICAN|Percentage: |-21.2 % Region: |NORTH AMERICAN|Percentage: |-15.97 % Region: |NORTH AMERICAN|Percentage: |2.16 % Region: |NORTH AMERICAN|Percentage: |2.6 % Region: |NORTH AMERICAN|Percentage: |6.64 %
 
Cost Structure Trend ( % ) in Global Generic Drugs Market (Source: Lucintel)
Expense2005200620072008200920102011
Cost of GoodsXXXXXXXXXXXXXX
Operating ProfitXXXXXXXXXXXXXX
Other ExpensesXXXXXXXXXXXXXX
R & D ExpenseXXXXXXXXXXXXXX
S G & A ExpenseXXXXXXXXXXXXXX
 
Gross Profit Trend ( % ) in Generic Drugs Market by Region (Source: Lucintel)
Region2005200620072008200920102011
North AmericanXXXXXXXXXXXXXX
EuropeanXXXXXXXXXXXXXX
Asia PacificXXXXXXXXXXXXXX
Rest of WorldXXXXXXXXXXXXXX
GlobalXXXXXXXXXXXXXX
 
Net Profit Trend ( % ) in Generic Drugs Market by Region (Source: Lucintel)
Region2005200620072008200920102011
North AmericanXXXXXXXXXXXXXX
EuropeanXXXXXXXXXXXXXX
Asia PacificXXXXXXXXXXXXXX
Rest of WorldXXXXXXXXXXXXXX
GlobalXXXXXXXXXXXXXX
Provide your feedback to Lucintel